SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Jan 23, 2020
Document Date
Jan 22, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.
Filer
Nicholson Garry A

Terms of Use | Copyright © 2020 Turning Point Therapeutics, Inc. | All Rights Reserved